273 related articles for article (PubMed ID: 17942928)
1. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines.
Yang B; O'Herrin SM; Wu J; Reagan-Shaw S; Ma Y; Bhat KM; Gravekamp C; Setaluri V; Peters N; Hoffmann FM; Peng H; Ivanov AV; Simpson AJ; Longley BJ
Cancer Res; 2007 Oct; 67(20):9954-62. PubMed ID: 17942928
[TBL] [Abstract][Full Text] [Related]
2. MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.
Bhatia N; Xiao TZ; Rosenthal KA; Siddiqui IA; Thiyagarajan S; Smart B; Meng Q; Zuleger CL; Mukhtar H; Kenney SC; Albertini MR; Jack Longley B
J Invest Dermatol; 2013 Mar; 133(3):759-767. PubMed ID: 23096706
[TBL] [Abstract][Full Text] [Related]
3. MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression.
Xiao TZ; Bhatia N; Urrutia R; Lomberk GA; Simpson A; Longley BJ
PLoS One; 2011; 6(8):e23747. PubMed ID: 21876767
[TBL] [Abstract][Full Text] [Related]
4. MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity.
Xiao TZ; Suh Y; Longley BJ
Arch Biochem Biophys; 2014 Dec; 563():136-44. PubMed ID: 25107531
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1.
Bhatia N; Yang B; Xiao TZ; Peters N; Hoffmann MF; Longley BJ
Arch Biochem Biophys; 2011 Apr; 508(2):217-21. PubMed ID: 21277283
[TBL] [Abstract][Full Text] [Related]
6. A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells.
Sakurai T; Itoh K; Higashitsuji H; Nagao T; Nonoguchi K; Chiba T; Fujita J
J Biol Chem; 2004 Apr; 279(15):15505-14. PubMed ID: 14739298
[TBL] [Abstract][Full Text] [Related]
7. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.
Tseng HY; Chen LH; Ye Y; Tay KH; Jiang CC; Guo ST; Jin L; Hersey P; Zhang XD
Carcinogenesis; 2012 Oct; 33(10):1871-81. PubMed ID: 22791814
[TBL] [Abstract][Full Text] [Related]
8. The melanoma antigen genes--any clues to their functions in normal tissues?
Ohman Forslund K; Nordqvist K
Exp Cell Res; 2001 May; 265(2):185-94. PubMed ID: 11302683
[TBL] [Abstract][Full Text] [Related]
9. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.
Monte M; Simonatto M; Peche LY; Bublik DR; Gobessi S; Pierotti MA; Rodolfo M; Schneider C
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11160-5. PubMed ID: 16847267
[TBL] [Abstract][Full Text] [Related]
10. Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.
Yang B; O'Herrin S; Wu J; Reagan-Shaw S; Ma Y; Nihal M; Longley BJ
J Invest Dermatol; 2007 Feb; 127(2):267-75. PubMed ID: 16960553
[TBL] [Abstract][Full Text] [Related]
11. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases.
Doyle JM; Gao J; Wang J; Yang M; Potts PR
Mol Cell; 2010 Sep; 39(6):963-74. PubMed ID: 20864041
[TBL] [Abstract][Full Text] [Related]
12. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
[TBL] [Abstract][Full Text] [Related]
13. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
14. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
15. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
16. A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.
Panelli MC; Bettinotti MP; Lally K; Ohnmacht GA; Li Y; Robbins P; Riker A; Rosenberg SA; Marincola FM
J Immunol; 2000 Apr; 164(8):4382-92. PubMed ID: 10754339
[TBL] [Abstract][Full Text] [Related]
17. MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
Marcar L; Ihrig B; Hourihan J; Bray SE; Quinlan PR; Jordan LB; Thompson AM; Hupp TR; Meek DW
PLoS One; 2015; 10(5):e0127713. PubMed ID: 26001071
[TBL] [Abstract][Full Text] [Related]
18. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
19. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
20. Tumor antigen expression in melanoma varies according to antigen and stage.
Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
